ASRT: Gonadal, fetal shielding still necessary during x-rays

The American Society of Radiologic Technologists (ASRT) Board of Directors announced more research is needed before recommending the removal of gonadal and fetal shielding during x-rays, despite another medical association’s call to end the practice.

“At this time, the ASRT Board cannot endorse the proposal to remove gonadal and fetal shielding,” according to the statement. “The Board believes the community needs to conduct more research, review the science and participate in further discussions to determine if the recommendation benefits patients and the radiologic technology community.”

In the statement, the board said the community “cannot take this issue lightly,” and that changing  radiation safety best practices that have been in place for decades would need alterations to educational programs, state statutes, certifications, facility protocols and patient expectations.

However, an April statement released by the American Association of Physicists in Medicine (AAPM) recommended the discontinuation of gonadal and fetal shielding during x-rays, noting it may “obscure anatomic information or interfere with the automatic exposure control of the imaging system.” Such effects could alter the diagnostic accuracy of an exam or increase radiation dose, according to the AAPM statement.

The ASRT carefully reviewed that statement, and many of its members and facilities did not agree with the recommendation to discontinue shielding.

The ASRT Board is planning to meet in the fall to discuss the issue, review scientific findings and better understand the complexities of the debate.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.